コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 trisomy 21 Down's syndrome (as confirmed by cytogenetic analysis).
2 abnormalities of chromosome 6 determined by cytogenetic analysis.
3 l imbalances not detectable with traditional cytogenetic analysis.
4 ultured separately and subjected to standard cytogenetic analysis.
5 ng 235 patients who had undergone successful cytogenetic analysis.
6 mber alterations that had been identified by cytogenetic analysis.
7 adequate for histopathologic examination and cytogenetic analysis.
8 aneuploidy status at higher sensitivity than cytogenetic analysis.
9 ll somatic deletions not evident by standard cytogenetic analysis.
10 omplexity than anticipated from conventional cytogenetic analysis.
11 n was suspected on the basis of conventional cytogenetic analysis.
12 thout relying on the success of conventional cytogenetic analysis.
13 tions often are not detected by conventional cytogenetic analysis.
14 eved a complete response by Southern blot or cytogenetic analysis.
15 ients with and without t(15; 17) on standard cytogenetic analysis.
16 y karyotyping and then by more sophisticated cytogenetic analysis.
21 a greater diagnostic yield than conventional cytogenetic analysis and more efficient risk stratificat
22 mice with mutations in ATM and/or p53 using cytogenetic analysis and mRNA transcriptional profiling.
24 immunohistochemistry combined with classical cytogenetic analysis and spectral karyotyping to investi
26 , possibly due to the limits of conventional cytogenetic analysis and the presence of different break
28 well-known aberrations detectable mostly by cytogenetic analysis, and these cases are classified as
30 pies of this repeat unit are identifiable by cytogenetic analysis as a previously described 8p23.1 eu
32 t presence of clonal evolution determined by cytogenetic analysis at progression was prognostic of su
33 gene rearrangements was compared with marrow cytogenetic analysis before the initiation of treatment
34 These results support the use of interphase cytogenetic analysis, but not IgVH, CD38 expression, or
39 years); 374 patients (94.7%) had genetic and cytogenetic analysis completed within 7 d and were centr
41 as defined by sequencing results instead of cytogenetic analysis, correlated with clinical outcomes.
52 analysed using chromatin fibre fluorography, cytogenetic analysis, immunofluorescence, and fluorescen
56 ify patients who had inconclusive results by cytogenetic analysis into risk groups in which clinical
60 the techniques, we use a recently published cytogenetic analysis of 206 melanoma cases to derive gra
65 CML should be monitored routinely by serial cytogenetic analysis of bone marrow until Ph negativity
69 Integration of molecular, phylogenetic, and cytogenetic analysis of dispersed repetitive DNA may she
71 FISH-based methods have greatly enhanced the cytogenetic analysis of hematopoietic and solid tumors a
74 who achieved a complete remission after DLI, cytogenetic analysis of marrow cells also demonstrated c
80 overcomes many of the limitations of routine cytogenetic analysis of POC samples while enhancing the
82 lasia, or fibrous dysplasia were examined by cytogenetic analysis of short-term cultures and bi-color
90 oietic stem-cell engraftment was verified by cytogenetic analysis or restriction-fragment--length pol
93 y-seven patients with aniridia, referred for cytogenetic analysis predominantly to assess Wilms tumor
96 graft studies combined with histological and cytogenetic analysis reveal that Separase-induced tumors
107 verestimating the degree of response, marrow cytogenetic analysis should be performed when patients a
108 a second unrelated family with signs of PMD, cytogenetic analysis showed a pericentric inversion of t
110 f CIN precedes tumor formation, quantitative cytogenetic analysis, SKY analysis, and quantitative cen
111 uencing and centromere mapping combined with cytogenetic analysis, small molecule inhibitors, and gen
112 f the long arm of chromosome 4 detectable by cytogenetic analysis (standard karyotyping), fluorescent
116 d molecular markers on chromosome 1L and (2) cytogenetic analysis using fluorescence in situ hybridiz
119 genetic studies, a result that suggests that cytogenetic analysis was not merely selecting for a mino
122 Among 3,578 patients with ALL and successful cytogenetic analysis, we identified 35 patients with the
123 ee of allelic loss underestimated by routine cytogenetic analysis, which failed to detect 9 of these